PRODUCT LITERATURE
Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
Many patients at high risk of cardiovascular disease do not achieve recommended low-density lipoprotein
cholesterol (LDL-C) goals. This study compared the efficacy and safety of low doses of rosuvastatin (10 mg) and
atorvastatin (20 mg) in high-risk patients with hypercholesterolemia
No other version available